News | November 18, 2021
Novavax and Serum Institute receive EUA for Covovax
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
It is a recombinant nanoparticle protein-based vaccine
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
The trial will be conducted across 10 sites in India
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Filing for WHO Emergency Use Authorisation this month
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Subscribe To Our Newsletter & Stay Updated
